NCT06896253View on ClinicalTrials.gov

Pulse Corticosteroids Or/and Immunoglobulins to Treat Fulminant Myocarditis

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

May 31, 2029

Study Completion Date

November 30, 2029

Conditions
Myocarditis Acute
Interventions
DRUG

Pulse bolus corticosteroids

Treatment administration

DRUG

Pulse bolus corticosteroids and IVIG

Treatment administration

DRUG

Pulse bolus corticosteroids (G5%) and IVIG (G5 %)

Treatment administration

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER